Manufacturer
NOVARTIS PHARMA STEIN AG
Contents
Secukinumab
Indication
Moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. Alone or in combination w/ methotrexate for active psoriatic arthritis in adult patients when response to previous disease-modifying anti-rheumatic drug therapy has been inadequate. Ankylosing spondylitis in adult who have responded inadequately to conventional therapy.
Instruction
Administered by subcutaneous injection
Drug interaction
Live vaccines.
Malaysia
